Wang Hong, Wang Hongli, Wei Yuyuan, Li Xinxin, Jhummun Vineet, Ahmed Mohamad A
Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, Guangxi, People's Republic of China.
Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
Diabetes Ther. 2021 Apr;12(4):1041-1054. doi: 10.1007/s13300-021-01025-x. Epub 2021 Feb 27.
In this meta-analysis, we aimed to systematically compare the 10-year outcomes of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in patients with type 2 diabetes mellitus (T2DM) suffering from left main coronary artery disease (LMCD).
Medical Literature Analysis and Retrieval System Online (MEDLINE), http://www.ClinicalTrials.gov , Excerpta Medica dataBASE (EMBASE), Cochrane Central, Web of Science, and Google scholar were searched for publications comparing 10-year outcomes of PCI versus CABG in patients with T2DM suffering from LMCD. Cardiovascular outcomes were considered as the clinical endpoints. Statistical analysis was carried out using RevMan software (version 5.4). Risk ratios (RR) with 95% confidence intervals (CI) were used to represent the data after analysis.
Eight studies (three randomized trials and five observational studies) with a total number of 3835 participants with T2DM were included in this analysis; 2340 participants were assigned to the PCI group and 1495 participants were assigned to the CABG group. Results of this analysis showed that mortality (RR 0.85, 95% CI 0.73-1.00; P = 0.05), myocardial infarction (RR 0.53, 95% CI 0.35-0.80; P = 0.002), repeated revascularization (RR 0.34, 95% CI 0.26-0.46; P = 0.00001), and target vessel revascularization (RR 0.26, 95% CI 0.18-0.38; P = 0.00001) were significantly higher with PCI when compared to CABG in these patients with diabetes and LMCD. Major adverse cardiac and cerebrovascular events were also significantly higher with PCI at 10 years (RR 0.67, 95% CI 0.49-0.92; P = 0.01). However, CABG was associated with a significantly higher risk of stroke (RR 2.16, 95% CI 1.39-3.37; P = 0.0007).
During a long-term follow-up time period of 10 years, PCI was associated with worse clinical outcomes compared to CABG in these patients with T2DM suffering from LMCD. However, a significantly higher risk of stroke was observed with CABG. This piece of information might be vital in order to carefully choose and prevent complications following revascularization in such patients.
在这项荟萃分析中,我们旨在系统比较经皮冠状动脉介入治疗(PCI)与冠状动脉旁路移植术(CABG)对患有2型糖尿病(T2DM)的左主干冠状动脉疾病(LMCD)患者的10年治疗效果。
通过检索医学文献分析与联机检索系统(MEDLINE)、http://www.ClinicalTrials.gov、医学文摘数据库(EMBASE)、Cochrane中心、科学引文索引和谷歌学术,查找比较PCI与CABG对患有LMCD的T2DM患者10年治疗效果的出版物。心血管结局被视为临床终点。使用RevMan软件(5.4版)进行统计分析。分析后的数据用风险比(RR)及95%置信区间(CI)表示。
本分析纳入了八项研究(三项随机试验和五项观察性研究),共有3835例T2DM患者;2340例患者被分配至PCI组,1495例患者被分配至CABG组。分析结果显示,在这些患有糖尿病和LMCD的患者中,与CABG相比,PCI组的死亡率(RR 0.85,95%CI 0.73 - 1.00;P = 0.05)、心肌梗死(RR 0.53,95%CI 0.35 - 0.80;P = 0.002)、再次血管重建(RR 0.34,95%CI 0.26 - 0.46;P = 0.00001)以及靶血管血管重建(RR 0.26,95%CI 0.18 - 0.38;P = 0.00001)显著更高。PCI组10年时的主要不良心脑血管事件也显著更高(RR 0.67,95%CI 0.49 - 0.92;P = 0.01)。然而,CABG与中风风险显著更高相关(RR 2.16,95%CI 1.39 - 3.37;P = 0.0007)。
在10年的长期随访期内,对于这些患有LMCD的T2DM患者,与CABG相比,PCI的临床结局更差。然而,CABG的中风风险显著更高。这一信息对于在此类患者血管重建后谨慎选择并预防并发症可能至关重要。